These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

151 related articles for article (PubMed ID: 7079160)

  • 41. Clinical practice. Calcium kidney stones.
    Worcester EM; Coe FL
    N Engl J Med; 2010 Sep; 363(10):954-63. PubMed ID: 20818905
    [No Abstract]   [Full Text] [Related]  

  • 42. [The significance of oxaluria reduction in pyridoxine prevention of Ca-oxalate nephrolithiasis (author's transl)].
    Revúsová V; Gratzlová J; Zvara V; Krídl J; Suchánek B
    Cas Lek Cesk; 1982 Feb; 121(6):163-6. PubMed ID: 7060073
    [No Abstract]   [Full Text] [Related]  

  • 43. Calcium restriction, thiazide, citrate, and allopurinol in calcium oxalate nephrolithiasis.
    Coe FL
    Acta Urol Belg; 1994 Jun; 62(2):25-9. PubMed ID: 8037000
    [No Abstract]   [Full Text] [Related]  

  • 44. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A
    Arch Esp Urol; 1999; 52(1):94-9. PubMed ID: 10101897
    [TBL] [Abstract][Full Text] [Related]  

  • 45. [The role of allopurinol in prevention of recurrences in calcic calculosis].
    Fiorelli C; Carini M; Nicita G; Rizzo M
    Minerva Urol; 1980; 32(3):153-60. PubMed ID: 7432330
    [No Abstract]   [Full Text] [Related]  

  • 46. [Diet and nutrition in nephrolitiasis].
    Miggiano GA; Migneco MG
    Clin Ter; 2007; 158(1):49-54. PubMed ID: 17405659
    [TBL] [Abstract][Full Text] [Related]  

  • 47. [Diuretic treatment of recurrent nephrolithiasis caused by idiopathic hypercalciuria].
    Birkenhäger JC; Lockefeer J; Bakker NJ
    Ned Tijdschr Geneeskd; 1972 Aug; 116(33):1485-6. PubMed ID: 5069838
    [No Abstract]   [Full Text] [Related]  

  • 48. Urinary lithogen risk test: usefulness in the evaluation of renal lithiasis treatment using crystallization inhibitors (citrate and phytate).
    Conte A; Pizá P; García-Raja A; Grases F; Costa-Bauzá A; Prieto RM
    Arch Esp Urol; 1999 Apr; 52(3):305-10. PubMed ID: 10371752
    [TBL] [Abstract][Full Text] [Related]  

  • 49. [Urinary lithiasis in the child (author's transl)].
    Gosalbez R; Garat JM; Piro C; Martin JA
    J Urol (Paris); 1980; 86(9):665-70. PubMed ID: 7205014
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Ten years' experience with the use of thiazides in the prevention of kidney stones.
    Yendt ER; Cohanim M
    Trans Am Clin Climatol Assoc; 1974; 85():65-75. PubMed ID: 4804100
    [No Abstract]   [Full Text] [Related]  

  • 51. Diet to reduce mild hyperoxaluria in patients with idiopathic calcium oxalate stone formation: a pilot study.
    Nouvenne A; Meschi T; Guerra A; Allegri F; Prati B; Fiaccadori E; Maggiore U; Borghi L
    Urology; 2009 Apr; 73(4):725-30, 730.e1. PubMed ID: 19193409
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Eicosapentaenoic acid has a preventive effect on the recurrence of nephrolithiasis.
    Yasui T; Suzuki S; Itoh Y; Tozawa K; Tokudome S; Kohri K
    Urol Int; 2008; 81(2):135-8. PubMed ID: 18758209
    [TBL] [Abstract][Full Text] [Related]  

  • 53. [Idiopathic hypercalciuria in childhood].
    Reusz G
    Orv Hetil; 1998 Dec; 139(49):2957-62. PubMed ID: 9879200
    [TBL] [Abstract][Full Text] [Related]  

  • 54. [Drinking water and urinary stones. Which drinking water and which modalities of diuresis?].
    Hubert J; Hubert C; Jungers P; Daudon M; Hartemann P
    Prog Urol; 2002 Sep; 12(4):692-9. PubMed ID: 12463138
    [TBL] [Abstract][Full Text] [Related]  

  • 55. [Nephrolithiasis-induced ESRD: frequency, causes and prevention].
    Jungers P; Joly D; Barbey F; Choukroun G; Daudon M
    Nephrol Ther; 2005 Nov; 1(5):301-10. PubMed ID: 16895699
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Carbonic anhydrase inhibitors and calcium phosphate stones].
    Barbey F; Nseir G; Ferrier C; Burnier M; Daudon M
    Nephrologie; 2004; 25(5):169-72. PubMed ID: 15455790
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Artificial neural networks for assessing the risk factors for urinary calcium stones according to gender and family history of stone.
    Dussol B; Verdier JM; Goff JM; Berthezene P; Berland Y
    Scand J Urol Nephrol; 2007; 41(5):414-8. PubMed ID: 17853052
    [TBL] [Abstract][Full Text] [Related]  

  • 58. [Certain clinical observations on Belascoain spa (Navarra) with special reference to hydromineral therapy of renal lithiasis].
    VAZQUEZ JO
    Med Colon; 1951 Aug; 18(2):83-100. PubMed ID: 14874805
    [No Abstract]   [Full Text] [Related]  

  • 59. Prevention of stone formation and bone loss in absorptive hypercalciuria by combined dietary and pharmacological interventions.
    Pak CY; Heller HJ; Pearle MS; Odvina CV; Poindexter JR; Peterson RD
    J Urol; 2003 Feb; 169(2):465-9. PubMed ID: 12544288
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Xanthinuria with xanthine lithiasis in a patient with Lesch-Nyhan syndrome under allopurinol therapy].
    Rebentisch G; Stolz S; Muche J
    Aktuelle Urol; 2004 Jun; 35(3):215-21. PubMed ID: 15258855
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.